Article Details

Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 ...

Retrieved on: 2025-01-02 11:53:19

Tags for this article:

Click the tags to see associated articles and topics

Innovent Enters into Exclusive Global License Agreement with Roche for Novel DLL3 .... View article details on hiswai:

Excerpt

SAN FRANCISCO and SUZHOU, China, Jan. 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical ...

Article found on: www.manilatimes.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo